Rapt Therapeutics, Inc.
RAPT
Revenue
0.00
0.000.00%
3 Months ChangeAssets
240.33M
▲131.86M▲121.57%
3 Months ChangeLiabilities
50.42M
▲37.46M▲289.08%
3 Months ChangeFree Cash Flow
-27.19M
▼-7.83M▼-40.43%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-08
Form 10-Q
ID: 0000950170-24-093354
2024-08-08
Form 8-K
ID: 0000950170-24-093350
2024-07-19
Form 8-K
ID: 0000950170-24-084991
2024-05-23
Form 8-K
ID: 0000950170-24-064001
2024-05-09
Form 10-Q
ID: 0000950170-24-056302
2024-05-09
Form 8-K
ID: 0000950170-24-056297
2024-03-07
Form 8-K
ID: 0000950170-24-027592
2024-02-22
Form 8-K
ID: 0000950170-24-018920
2024-02-20
Form 8-K
ID: 0000950170-24-017155
2023-11-13
Form 10-Q
ID: 0000950170-23-062471